NIH

Politics By Dylan Scott

Medical research’s best hope under President Trump? It’s Newt

Politics By Sheila Kaplan

Trump’s victory is a likely roadblock to medical ‘cures’ package

Politics By Sharon Begley

Fearful of a Trump administration, many in research call for a ‘tutorial’ for the president-elect

Politics By Charles Piller

New federal rules target woeful public reporting of clinical trial results

Politics By David Nather

Obama administration, shifting money to fight Zika, says funds are tapped out

In the Lab By Andrew Joseph

NIH considering restarting funding for human-animal chimera research

Health By Dylan Scott

New York City’s first lady explains why she’s so open about mental illness

In the Lab By Andrew Joseph

US researchers now testing Zika vaccines in human subjects

In the Lab By Carolyn Abraham

An ugly summer for science: Turmoil rocks Canadian research community

Quick Take By Lindzi Wessel

Female scientists face gender bias in NIH grant process

Health By Emily Bazar — Kaiser Health News

Government listing of clinical trials doesn’t disclose costs to patients

In the Lab By Sheila Kaplan

Columbia University fined nearly $10 million for sending inflated bills to NIH

Politics By Dylan Scott

House panel set to endorse $1.3 billion increase for the NIH

In the Lab By Sheila Kaplan

In clinical trials, for-profit review boards are taking over for hospitals. Should they?

Politics By David Nather

Biden to unveil effort to speed researchers’ access to cancer drugs

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: India revising laws to upgrade drug safety

Pharmalot By Ed Silverman

NIH rejects petition to override patent on pricey prostate cancer drug